Mikhail Chernov
Professor
Department of Cell Stress Biology
Roswell Park Cancer Institute
United States of America
Biography
Dr. Chernov joined the staff of Roswell Park Cancer Institute (RPCI) in July of 2007, as a Director of Small Molecule Screening Core Facility in the Department of Cell Stress biology.Dr. Chernov earned an MS degree in Biochemistry and Physiology from Moscow State University (Moscow Russia) and his Ph.D. in Biochemistry in 1987 from the Cancer Research Center (Moscow Russia).Dr. Chernov has authored or co-authored more than 30 journal publications, and abstracts.
Research Interest
study of regulation and function of p53 tumor suppressor and development and utilization of cell based readout systems for drug discovery.
Publications
-
Jegede O, Khodyakova A, Chernov M, Weber J, Menendez-Arias L, et al. (2011) Identification of low molecular weight inhibitors of HIV 1 reverse transcriptase using a cell based high throughput screening system. Antiviral research 91: 94-98
-
Hu Y, Spengler ML, Kuropatwinski KK, Comas-Soberats M, Chernov MV, et al. (2011) Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1. Oncotarget 2: 1279-1290
-
Antoch MP, Chernov MV, (2009) Pharmacological modulators of the circadian clock as potential therapeutic drugs. Mutation research. Genetic toxicology and environmental mutagenesis 680: 109-115
